Peritoneal Dialysis for Patients With Polycystic Kidney Disease in Spain

2011 ◽  
Vol 58 (3) ◽  
pp. 493 ◽  
Author(s):  
Jose M. Portoles ◽  
Ana M. Tato ◽  
Paula López-Sánchez
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Polycystic Kidney

scholarly journals A Case Report of Autosomal Dominant Polycystic Kidney Disease Under Peritoneal Dialysis With Cyst Infection and Culture-Positive Peritoneal Fluid

2019 ◽  
Vol 12 ◽  
pp. 117954761984686 ◽  
Author(s):  
Itaru Yasuda ◽  
Kazuhiro Hasegawa ◽  
Hirobumi Tokuyama ◽  
Naoki Washida ◽  
Keisuke Shinozuka ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Blood Culture ◽  
Polycystic Kidney Disease ◽  
Peritoneal Fluid ◽  
Autosomal Dominant ◽  
Polymorphonuclear Leucocytes ◽  
Polycystic Kidney ◽  
Cyst Infection ◽  
Autosomal Dominant Polycystic Kidney

Background: Cyst infection is a complication sometimes seen in patients with autosomal dominant polycystic kidney disease (ADPKD) and often shows through a positive blood culture. However, there have been no reports of ADPKD patients whose cyst infection propagate to peritoneal fluid leading to positive peritoneal fluid culture. Case presentation: A 74-year-old Japanese man with ADPKD under peritoneal dialysis (PD) was presented with left flank pain, fever, and chills at our hospital. He did not show any symptoms or signs suggestive of peritonitis. There were no elevated cell counts or polymorphonuclear leucocytes in his PD fluid. There were some complicated cysts found in computed tomography and magnetic resonance imaging examinations. We clinically diagnosed him as having a renal cyst infection rather than PD-related peritonitis. We initiated treatment by administering ceftriaxone with an immediate favorable response. As the possibility of accompanying prostatitis still remained, we switched to intravenous levofloxacin on the second day. On the 10th day, Helicobacter cinaedi was detected in 2 sets of blood culture as well as in PD fluid. We switched back to ceftriaxone and this treatment was entirely successful. Conclusions: This is the first report of H cinaedi cyst infection which propagates to peritoneal fluid in a patient with ADPKD.

scholarly journals Comparison of mortality between peritoneal dialysis and hemodialysis in polycystic kidney disease

Renal Failure ◽  
2019 ◽  
Vol 41 (1) ◽  
pp. 14-15
Author(s):  
Xingxing Fang ◽  
Meizi Kang ◽  
Dongmei Chen ◽  
Lianglan Shen
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Polycystic Kidney

Peritoneal Dialysis for Patients with Autosomal Dominant Polycystic Kidney Disease

2017 ◽  
Vol 37 (4) ◽  
pp. 384-388 ◽  
Author(s):  
Sana Khan ◽  
Anna Giuliani ◽  
Carlo Crepaldi ◽  
Claudio Ronco ◽  
Mitchell H. Rosner
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Autosomal Dominant ◽  
Disease Patient ◽  
Cystic Kidney ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney ◽  
Stage Renal Disease ◽  
End Stage

End-stage renal disease secondary to autosomal dominant poly-cystic kidney (ADPKD) is a common issue worldwide. Peritoneal dialysis (PD) is a reasonable option for renal replacement therapy for these patients and should not be withheld due to concerns that the patient may not tolerate the fluid volumes in the peritoneal cavity. This review covers the existing data on the outcomes and complications associated with the use of PD in the polycystic kidney disease patient. In general, PD is well tolerated and outcomes in ADPKD patients are equivalent to or better than other patient groups.

scholarly journals Patients’ outcome with polycystic kidney disease firstly treated with peritoneal dialysis. Experience of our home dialysis unit since 1997.

2021 ◽  
Vol 4 (1) ◽  
pp. 11-19
Author(s):  
Jean-michel Poux ◽  
Carlos Cardozo ◽  
Laville Maurice ◽  
Anne Jolivot ◽  
Jean-Pierre Fauvel
Keyword(s):  
Peritoneal Dialysis ◽  
Renal Transplantation ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Medical Monitoring ◽  
Automated Peritoneal Dialysis ◽  
Polycystic Kidney ◽  
Dialysis Unit ◽  
Home Dialysis ◽  
Hemodialysis Unit

We extracted data from the French Speaking Registry of Peritoneal Dialysis and retrospectively studied peritonitis and the outcome of 30 patients with polycystic kidney disease firstly treated with peritoneal dialysis within our dialysis unit since 1997. There were 15 men and 15 women with a mean age of 54 years. Eighty-five per-cent of the patients had hepatic impairment. Ten patients did not suffer from comorbidities. Charlson comorbidity index was greater than or equal to 4 in five patients. Most of the patients was treated with automated peritoneal dialysis during the night. Only one patient was not autonomous with peritoneal dialysis. The whole medical monitoring lasted 836 months, representing an average of 28 months per patient. Eleven patients had a total of 24 peritonitis, 9 with gram negative bacillus. The incidence of peritonitis was one episode every 35 months-patient. Peritonitis was responsible for sudden admission in hemodialysis unit in two cases and death in one case. Fifteen patients (50%) benefited from renal transplantation. Only one patient had to undergo nephrectomy prior to renal transplantation. Seven patients were admitted to hemodialysis unit (the median duration time on peritoneal dialysis was 36 months). Four patients died. Four patients are currently treated with peritoneal dialysis. In conclusion, this retrospective study points out that peritoneal dialysis, especially automated peritoneal dialysis, is a good option for patients with polycystic kidney disease necessitating dialysis.

Intraperitoneal Pressure in Polycystic and Non-Polycystic Kidney Disease Patients, Treated by Peritoneal Dialysis

2020 ◽  
Vol 49 (6) ◽  
pp. 670-676
Author(s):  
Anna Giuliani ◽  
Sabrina Milan Manani ◽  
Carlo Crepaldi ◽  
Alessandro Domenici ◽  
Fiorella Gastaldon ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Significant Positive Correlation ◽  
Inverse Correlation ◽  
Polycystic Kidney ◽  
Significant Inverse Correlation ◽  
Intraperitoneal Pressure ◽  
Wide Range ◽  
Wide Variability

<b><i>Introduction:</i></b> Intraperitoneal volume (IPV) should be individualized and aimed to maintain an intraperitoneal pressure (IPP) lower than 17 cm H<sub>2</sub>O. IPP is very variable, given its relation with body size. However, it is not yet fully understood which anthropometric variable mostly affects IPP and the relation between IPP and organomegaly in polycystic kidney disease (PKD) patients is not known. <b><i>Objectives:</i></b> The aim of the present study was to analyse the relation between antropometric variables and IPP in a large cohort of peritoneal dialysis (PD) patients and to identify if a relation between nephromegaly and IPP exists in PKD patients. <b><i>Methods:</i></b> IPP was measured in PD patients and data was retrospectively collected. In PKD patients, total kidney volumes were measured in CT scans, and normalized with height (hTKV). <b><i>Results:</i></b> Seventy-seven patients were included in the study, 18% affected by PKD. Mean IPP was 14.9 ± 2.9 cm H<sub>2</sub>O and it showed significant positive correlation with body mass index (BMI; <i>ρ</i> = 0.42, <i>p</i> &#x3c; 0.001). No correlation was found between IPP and absolute IPV; conversely, IPP has a significant inverse correlation with IPV normalized with BMI and body surface area (<i>ρ</i> –0.38, <i>p</i> = 0.001 and <i>ρ</i> –0.25, <i>p</i> = 0.02, ­respectively). Patients with IPP &#x3e;17 cm H<sub>2</sub>O have significant larger BMI and lower IPV/BMI compared to those with IPP &#x3c;17 cm H<sub>2</sub>O (29 ± 3.6 vs. 26 ± 4 kg/m<sup>2</sup>, <i>p</i> &#x3c; 0.05 and 97 ± 15.5 vs. 109 ± 22 mL/kg/m<sup>2</sup>, <i>p</i> &#x3c; 0.05). PKD patients have a wide variability in hTKV (range 645–3,787 mL/m<sup>2</sup>) and it showed a significant correlation with IPP/IPV (<i>ρ</i> = 0.6, <i>p</i> &#x3c; 0.05). <b><i>Conclusions:</i></b> Patients with larger BMI have greater IPP, irrespectively to IPV. In PKD patients, hTKV correlate with IPP/IPV ratio. However, given the wide range of distribution of hTKV, increased IPP cannot be presumed because of pre-existing polycystic kidney, but need to be quantified.

scholarly journals Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF)

2010 ◽  
Vol 26 (7) ◽  
pp. 2332-2339 ◽  
Author(s):  
T. Lobbedez ◽  
M. Touam ◽  
D. Evans ◽  
J.-P. Ryckelynck ◽  
B. Knebelman ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Polycystic Kidney
Sign in / Sign up

Export Citation Format

Share Document